Borderless
innovations
to cure HIV
About EU2Cure
The EU2Cure consortium is a Europe-wide alliance of HIV clinician-scientists, researchers, community advocates, and funders working together to accelerate progress toward an HIV cure.
By leveraging cross-border collaboration, coordinated EU funding, and evidence-based policy frameworks, EU2Cure drives innovation from basic science through advanced clinical trials, while training the next generation of HIV cure leaders and ensuring equitable access to breakthroughs.
The consortium brings together 15 academic and community institutions across 11 European countries, united by a shared vision: for Europe to lead the global effort to develop and deliver a clinically feasible HIV cure.
Informazioni su EU2Cure
Sobre EU2Cure
About the consortium
The EU2Cure Consortium combines complementary expertise in virology, immunology, clinical trials, and community engagement. Our collaborative structure fosters innovation, data sharing, and coordinated research efforts across borders, demonstrating true European added value.
A proposito del consorzio
Sobre el consorcio
Latest news
First collaborative study: EU2Control
We're launching an international study in 11 European countries to learn more about people who can control HIV after having stopped treatment. .....
read moreCharles Boucher's obituary
Prof. Charles Achim Bernard Boucher, a pioneering HIV researcher, died early in the morning on February 26th at his home in Utrecht, aged 63......
read moreLaunching a multidisciplinary European collaboration towards a cure for HIV
The EU2Cure Consortium.....
read more
Contact us
Would you like to participate in a study, are you interested in collaborating with us, or do you want to invest? Fill in the form and we will contact you, or contact us directly via the e-mail address below!